Regulus Therapeutics Inc (RGLS):企業の財務・戦略的SWOT分析

◆英語タイトル:Regulus Therapeutics Inc (RGLS) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14806
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target microRNAs. Its lead product candidates include RG-012, an anti-miR targeting miR-21 in Phase II clinical trial for the treatment of Alport syndrome; and RGLS4326, an anti-miR targeting miR-17 in Phase I clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company’s products are used in the therapeutic areas of hepatitis C infection, cardiovascular disease, cancer, fibrosis, immune inflammatory diseases and metabolic diseases, among others. Regulus Therapeutics. Regulus Therapeutics is headquartered in San Diego, California, the US.

Regulus Therapeutics Inc Key Recent Developments

Nov 19,2018: Regulus Presents Preclinical Survival Data Highlighting Potential of Novel Treatment for Glioblastoma Multiforme
Nov 08,2018: Regulus reports third quarter 2018 financial results and recent updates
Oct 25,2018: Regulus to Present Data from ATHENA, a Global Natural History of Disease Study for Alport Syndrome, at ASN’s Kidney Week 2018
Oct 22,2018: Regulus to Present Preclinical Data Supporting RGLS4326 as a Novel Therapeutic in Development for Autosomal Dominant Polycystic Kidney Disease at ASN’s Kidney Week 2018
Sep 27,2018: Regulus to Present at the Cantor Fitzgerald Global Healthcare Conference

This comprehensive SWOT profile of Regulus Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Regulus Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Regulus Therapeutics Inc – Key Information
Regulus Therapeutics Inc – Overview
Regulus Therapeutics Inc – Key Employees
Regulus Therapeutics Inc – Key Employee Biographies
Regulus Therapeutics Inc – Key Operational Heads
Regulus Therapeutics Inc – Major Products and Services
Regulus Therapeutics Inc – History
Regulus Therapeutics Inc – Company Statement
Regulus Therapeutics Inc – Locations And Subsidiaries
Regulus Therapeutics Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Regulus Therapeutics Inc – Business Description
Regulus Therapeutics Inc – Corporate Strategy
Regulus Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Regulus Therapeutics Inc – Strengths
Regulus Therapeutics Inc – Weaknesses
Regulus Therapeutics Inc – Opportunities
Regulus Therapeutics Inc – Threats
Regulus Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Regulus Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Regulus Therapeutics Inc, Key Information
Regulus Therapeutics Inc, Key Ratios
Regulus Therapeutics Inc, Share Data
Regulus Therapeutics Inc, Major Products and Services
Regulus Therapeutics Inc, History
Regulus Therapeutics Inc, Key Employees
Regulus Therapeutics Inc, Key Employee Biographies
Regulus Therapeutics Inc, Key Operational Heads
Regulus Therapeutics Inc, Other Locations
Regulus Therapeutics Inc, Subsidiaries
Regulus Therapeutics Inc, Key Manufacturing facilities
Regulus Therapeutics Inc, Key Competitors
Regulus Therapeutics Inc, SWOT Analysis
Regulus Therapeutics Inc, Ratios based on current share price
Regulus Therapeutics Inc, Annual Ratios
Regulus Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Regulus Therapeutics Inc, Performance Chart
Regulus Therapeutics Inc, Ratio Charts

★海外企業調査レポート[Regulus Therapeutics Inc (RGLS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genworth Financial, Inc.:企業の戦略・SWOT・財務情報
    Genworth Financial, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genworth Financial, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sernova Corp (SVA):企業の製品パイプライン分析2018
    Summary Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like …
  • Titan Machinery Inc (TITN):企業の財務・戦略的SWOT分析
    Titan Machinery Inc (TITN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Minnkota Power Cooperative Inc:発電所・企業SWOT分析
    Minnkota Power Cooperative Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Protokinetix Inc (PKTX):企業の財務・戦略的SWOT分析
    Summary ProtoKinetix Inc (ProtoKinetix) is a biotechnology company that develops solutions for cell survival and health. The company develops anti-aging glycopeptides used to protect cell lines including hela cells, neonatal fibroblasts, adult fibroblast, human neuronal stem cells, CD34+ cells and k …
  • Nippon Steel & Sumitomo Metal Corp:企業の戦略・SWOT・財務情報
    Nippon Steel & Sumitomo Metal Corp - Strategy, SWOT and Corporate Finance Report Summary Nippon Steel & Sumitomo Metal Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Gilead Sciences Inc (GILD):企業の財務・戦略的SWOT分析
    Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Bone Biologics Corp (BBLG):企業の製品パイプライン分析
    Summary Bone Biologics Corp (Bone Biologics) is a biotechnology company that develops orthobiologic products. It develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers N …
  • Nestle Australia Ltd:企業の戦略・SWOT・財務分析
    Nestle Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Nestle Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Grand Hotel Varna Resort & Spa:企業の戦略・SWOT・財務情報
    Grand Hotel Varna Resort & Spa - Strategy, SWOT and Corporate Finance Report Summary Grand Hotel Varna Resort & Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Motor Oil (Hellas) Corinth Refineries SA (MOH):企業の財務・戦略的SWOT分析
    Motor Oil (Hellas) Corinth Refineries SA (MOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • TFS Financial Corp:企業の戦略・SWOT・財務分析
    TFS Financial Corp - Strategy, SWOT and Corporate Finance Report Summary TFS Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Peregrine Holdings Ltd:企業の戦略・SWOT・財務分析
    Peregrine Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Peregrine Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Araca Energy ASA:石油・ガス:M&Aディール及び事業提携情報
    Summary Araca Energy ASA (Araca Energy), formerly Aladdin Oil & Gas Company ASA is an oil and gas company that explores, acquires, extracts, develops, and produces oil and gas assets in Russia and other countries. The company conducts its oil and gas exploration, production and operations through it …
  • ITC Holdings Corp.:発電所・企業SWOT分析
    ITC Holdings Corp. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Oglethorpe Power Corporation:企業の戦略・SWOT・財務分析
    Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report Summary Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • Xylem Inc.:企業の戦略・SWOT・財務情報
    Xylem Inc. - Strategy, SWOT and Corporate Finance Report Summary Xylem Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Kentucky Power Co:企業の発電所・SWOT分析2018
    Kentucky Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Triple Energy Ltd (TNP):企業の財務・戦略的SWOT分析
    Summary Triple Energy Ltd (Triple Energy) is an oil and gas company that explores for natural resources. The company invests in oil and gas projects in the conventional and unconventional sectors such as coal seam gas and shale oil and gas, along with power generation. It offers project such as CFT …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆